COMMISSIONED EQUITY RESEARCH

TALLINK: All about the Dividend

Q3 Sales and Profits beat estimates, but the economic downturn affects demand. In 2025, we assume an economic recovery leading to a double- digit underlying profit growth. We expect dividend policy payouts each year in 2024-26.

COMMISSIONED EQUITY RESEARCH

CRUNCHFISH: Rights issue to stay the course on extended timeline

Read More Read Less

COMMISSIONED EQUITY RESEARCH

GRANGEX: Emerging as Europe’s top DR concentrate developer

Read More Read Less

COMMISSIONED EQUITY RESEARCH

GRANGEX: Updated DFS confirming viability to produce high-grade iron ore at Dannemora

Read More Read Less

COMMISSIONED EQUITY RESEARCH

PROLIGHT: Pre-validation readout in Q4 sets stage for multicenter trial in 2025

Read More Read Less

COMMISSIONED EQUITY RESEARCH

Nanexa AB: NEX-22 Progress, Revaluation and Financing

Read More Read Less

COMMISSIONED EQUITY RESEARCH

CRUNCHFISH: Three avenues to address the strained financing

Read More Read Less

COMMISSIONED EQUITY RESEARCH

Prolight Diagnostics: SEK 17m UK grant a welcome external validation

Read More Read Less

COMMISSIONED EQUITY RESEARCH

NANEXA: Insights from CMD underscore near- to mid-term opportunities with significant potential

Read More Read Less

COMMISSIONED EQUITY RESEARCH

GRANGEX: Striking renegotiation of Sydvaranger acquisition setting GRANGEX up for an eventful 2024

Read More Read Less

COMMISSIONED EQUITY RESEARCH

CRUNCHFISH: Broadening of scope to all offline credentials

Read More Read Less

COMMISSIONED EQUITY RESEARCH

PROLIGHT: Important milestone amidst mixed news flow

Read More Read Less

COMMISSIONED EQUITY RESEARCH

CRUNCHFISH: Major TAM expansion with broadening to secure and scalable mobile card payments

Read More Read Less

COMMISSIONED EQUITY RESEARCH

PROLIGHT: PoC troponin testing ready for next step

Read More Read Less

COMMISSIONED EQUITY RESEARCH

NANEXA: Focus on dual GLP-1 opportunities and the partner projects

Read More Read Less

COMMISSIONED EQUITY RESEARCH

GRANGEX: Starting to fuel up: GRANGEX set for busy agenda in 2024

Read More Read Less